Clinical Trials Directory

Trials / Completed

CompletedNCT01439802

Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery

Transcesarean IUD Insertion: A Prospective Cohort Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Albert Einstein College of Medicine · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the expulsion rates of copper Intrauterine Devices (IUDs) placed at time of Cesarean Delivery.

Detailed description

This was a prospective clinical study with 90 patients undergoing cesarean section. After delivery of the placenta, a ParaGard® copper T380A IUD was inserted through the hysterotomy site. IUD placement was confirmed by visualization of the strings at the cervical os or via ultrasound at the 6 week postpartum visit. Subjects also received a phone call 6 months after IUD placement to ascertain physician follow-up and patient satisfaction. This telephone call was to ensure that each subject attended her postpartum visit, had an evaluation of IUD placement and then we performed a survey. This survey used a Likert Scale to measure each subject's satisfaction. The fields included very satisfied, satisfied, somewhat satisfied, neutral, somewhat unsatisfied, unsatisfied and very unsatisfied.

Conditions

Interventions

TypeNameDescription
DEVICECopper IUD placement at time Cesarean Delivery (Copper T 380A)Placement of Paragard IUD at time of Cesarean Delivery

Timeline

Start date
2008-08-01
Primary completion
2009-11-01
Completion
2010-05-01
First posted
2011-09-23
Last updated
2023-04-07
Results posted
2022-12-29

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01439802. Inclusion in this directory is not an endorsement.